Sigma Healthcare (ASX:SIG) said its Chemist Warehouse unit reported preliminary unaudited total retail network sales of AU$5.15 billion in the fiscal half ended December 2024, compared with AU$4.56 billion a year earlier, according to a Tuesday filing with the Australian bourse.
The pharmacy's preliminary unaudited total like-for-like retail network sales grew 10.3% compared with an 8.9% growth the previous year, driven by a strong trading performance in December 2024, the filing said.
Shares of Sigma Healthcare rose 8% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.